These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32114427)

  • 61. Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.
    Semb AG; Ikdahl E; Hisdal J; Olsen IC; Rollefstad S
    Int J Cardiol; 2016 Nov; 223():331-336. PubMed ID: 27543704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ultrasound vascular screening for cardiovascular risk assessment. Why, when and how?
    Naqvi TZ
    Minerva Cardioangiol; 2006 Feb; 54(1):53-67. PubMed ID: 16467742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
    Mortensen MB; Falk E
    BMJ Open; 2014 Oct; 4(10):e005991. PubMed ID: 25326211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial.
    Sjölander M; Carlberg B; Norberg M; Näslund U; Ng N
    JAMA Netw Open; 2021 Aug; 4(8):e2121683. PubMed ID: 34410393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population.
    Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH
    J Hypertens; 2009 Dec; 27(12):2351-7. PubMed ID: 19915482
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calcium detection, its quantification, and grayscale morphology-based risk stratification using machine learning in multimodality big data coronary and carotid scans: A review.
    Banchhor SK; Londhe ND; Araki T; Saba L; Radeva P; Khanna NN; Suri JS
    Comput Biol Med; 2018 Oct; 101():184-198. PubMed ID: 30149250
    [TBL] [Abstract][Full Text] [Related]  

  • 67. American society of echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology.
    Roman MJ; Naqvi TZ; Gardin JM; Gerhard-Herman M; Jaff M; Mohler E; ;
    Vasc Med; 2006 Nov; 11(3):201-11. PubMed ID: 17288128
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention.
    Bard RL; Kalsi H; Rubenfire M; Wakefield T; Fex B; Rajagopalan S; Brook RD
    Am J Cardiol; 2004 Apr; 93(8):1030-2. PubMed ID: 15081449
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity.
    Faeh D; William J; Yerly P; Paccaud F; Bovet P
    Cardiovasc Diabetol; 2007 Oct; 6():32. PubMed ID: 17958881
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis.
    Ungprasert P; Matteson EL; Crowson CS
    Am J Cardiol; 2017 Sep; 120(5):868-873. PubMed ID: 28705378
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
    Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
    Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
    Hoke M; Amighi J; Mlekusch W; Schlager O; Exner M; Sabeti S; Dick P; Koppensteiner R; Minar E; Rumpold H; Wagner O; Schillinger M
    Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [ESC/EASD joint guidelines on diabetes and cardiovascular diseases].
    Motz W; Dörr R; ;
    Herz; 2009 Feb; 34(1):21-9. PubMed ID: 19214406
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High prevalence of subclinical atherosclerosis by carotid ultrasound among Mexican Americans: discordance with 10-year risk assessment using the Framingham risk score.
    Laing ST; Smulevitz B; Vatcheva KP; Rentfro AR; McPherson DD; Fisher-Hoch SP; McCormick JB
    Echocardiography; 2012 Nov; 29(10):1224-32. PubMed ID: 22747630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease.
    Sobchak C; Akhtari S; Harvey P; Gladman D; Chandran V; Cook R; Eder L
    Arthritis Rheumatol; 2019 Oct; 71(10):1651-1659. PubMed ID: 31165591
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of carotid intima-media thickness in an insurance context.
    Pokorski R
    J Insur Med; 2009; 41(2):127-31. PubMed ID: 19845215
    [TBL] [Abstract][Full Text] [Related]  

  • 77. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis.
    Grønholdt ML
    Neuroimaging Clin N Am; 2002 Aug; 12(3):421-35. PubMed ID: 12486830
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).
    Belcaro G; Nicolaides AN; Ramaswami G; Cesarone MR; De Sanctis M; Incandela L; Ferrari P; Geroulakos G; Barsotti A; Griffin M; Dhanjil S; Sabetai M; Bucci M; Martines G
    Atherosclerosis; 2001 Jun; 156(2):379-87. PubMed ID: 11395035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The case for statin use to reduce perioperative adverse cardiovascular and cerebrovascular events.
    Ratcliffe F; Rothwell PM
    Br J Anaesth; 2020 May; 124(5):525-534. PubMed ID: 32111371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.